The new Australian Government promises nearly AUD 1 billion in investments to Medicare and general practices as part of a number of policy commitments to healthcare and aged care initiatives.
On 21 May 2022, Australia elected a new federal government, the Australian Labor Party. As part of its campaign, the newly elected Federal Government committed to a number of healthcare and aged care policy initiatives with a strong focus on improving quality and access to primary care.
How do life sciences companies intend to leverage new and existing sources of growth? Explore the trajectory of life sciences transactions in our latest report.
As digital transformation reshapes business models with different emphases across regions, digitally enabled strategies are helping companies transition from product-only offerings to product-service hybrids, orient to patient mapping, pre-diagnostics solutions and enhancing treatment administration.
This report, the fourth in our Asia Pacific Business Renewal Series, explores how businesses are now fortifying their ESG efforts and pivoting from strategy to action. As businesses integrate ESG action into business renewal, there is an imperative to mitigate risks and pre-empt regulatory and compliance complexities amid uneven recovery and progress across jurisdictional and sectoral landscapes in the region.
This report, the fourth in our Asia Pacific Business Renewal Series, explores how businesses are now fortifying their ESG efforts and pivoting from strategy to action.
Click to read Digital healthcare, a globally booming market, has been catalyzed by the events of COVID-19. In Asia Pacific, in particular, a rapidly expanding population, an empowered and tech-savvy middle class and physician shortage has created the perfect conditions for digital health innovation. A new era of digital healthcare…
The Baker McKenzie Healthcare & Life Science Industry Group presented the first of a series of short webinars sharing legal industry insights and providing practical guidance in the context of today’s evolving world. On 17-18 November 2020, the session focused on a region-by-region view of the evolving compulsory licensing regimes during the COVID-19 pandemic.
With the healthcare and life sciences sector at the heart of the pandemic, we are seeing some new issues arising in the already complex world of life sciences collaborations, for both coronavirus-related and other products and therapies. The Life Sciences Collaborations: Key Considerations in the COVID-19 Era document is a…
Export from Australia of hand sanitiser, face masks and other infection control items are temporarily prohibited effective 30 March 2020. The Customs (Prohibited Exports) Amendment (COVID-19 Human Biosecurity Emergency) Regulations 2020 (Cth) (Regulation) amended the Customs (Prohibited Exports) Regulations 1958 (Cth) to temporarily prohibit export of goods that are key…